These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31174402)

  • 1. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus.
    Zhou C; Tan L; Sun Y; Qiu X; Liao Y; Song C; Liu W; Nair V; Ding C
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31174402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDV related exosomes enhance NDV replication through exporting NLRX1 mRNA.
    Xu X; Zhang D; Ding W; Wang W; Jin N; Ding Z
    Vet Microbiol; 2021 Sep; 260():109167. PubMed ID: 34274763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA gga-miR-455-5p suppresses Newcastle disease virus replication via targeting cellular suppressors of cytokine signaling 3.
    Wang X; Jia Y; Ren J; Liu H; Xiao S; Wang X; Yang Z
    Vet Microbiol; 2019 Dec; 239():108460. PubMed ID: 31767079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus.
    Fournier P; Wilden H; Schirrmacher V
    Int J Oncol; 2012 Jan; 40(1):287-98. PubMed ID: 21971670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
    Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
    Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRS Facilitates Newcastle Disease Virus Replication in Tumor Cells by Promoting Viral Budding.
    Chen Y; Wang C; Hu S; Liu X
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of viral components in exosomes derived from NDV-infected DF-1 cells and their promoting ability in virus replication.
    Xu X; Qian J; Ding J; Li J; Nan F; Wang W; Qin Q; Fei Y; Xue C; Wang J; Yin R; Ding Z
    Microb Pathog; 2019 Mar; 128():414-422. PubMed ID: 30597256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 3 inhibits Newcastle disease virus replication through activation of pro-inflammatory cytokines and the type-1 interferon pathway.
    Cheng J; Sun Y; Zhang X; Zhang F; Zhang S; Yu S; Qiu X; Tan L; Song C; Gao S; Wu Y; Ding C
    Arch Virol; 2014 Nov; 159(11):2937-48. PubMed ID: 24934575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.
    Buijs PR; van Eijck CH; Hofland LJ; Fouchier RA; van den Hoogen BG
    Cancer Gene Ther; 2014 Jan; 21(1):24-30. PubMed ID: 24384773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
    García-Romero N; Palacín-Aliana I; Esteban-Rubio S; Madurga R; Rius-Rocabert S; Carrión-Navarro J; Presa J; Cuadrado-Castano S; Sánchez-Gómez P; García-Sastre A; Nistal-Villan E; Ayuso-Sacido A
    Cells; 2020 Jun; 9(6):. PubMed ID: 32516884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gga-miR-1603 and gga-miR-1794 directly target viral L gene and function as a broad-spectrum antiviral factor against NDV replication.
    Chen Y; Zhu S; Hu J; Hu Z; Liu X; Wang X; Gu M; Hu S; Liu X
    Virulence; 2021 Dec; 12(1):45-56. PubMed ID: 33372825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
    Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK
    J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle disease virus selectively infects dividing cells and promotes viral proliferation.
    Chu Z; Gao X; Liu H; Ma J; Wang C; Lu K; Han Q; Wang Y; Wang C; Adam FEA; Wang X; Xiao S; Yang Z
    Vet Res; 2019 Apr; 50(1):27. PubMed ID: 30999941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication.
    Chen Y; Zhu S; Pei Y; Hu J; Hu Z; Liu X; Wang X; Gu M; Hu S; Liu X
    Front Oncol; 2021; 11():616809. PubMed ID: 34150610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
    Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
    Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Replication of Virulent Newcastle Disease Virus in Chicken Macrophages Is due to Polarized Activation of Cells by Inhibition of TLR7.
    Zhang P; Ding Z; Liu X; Chen Y; Li J; Tao Z; Fei Y; Xue C; Qian J; Wang X; Li Q; Stoeger T; Chen J; Bi Y; Yin R
    Front Immunol; 2018; 9():366. PubMed ID: 29670609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.